Correlation Between Unicycive Therapeutics and ProMIS Neurosciences
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and ProMIS Neurosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and ProMIS Neurosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and ProMIS Neurosciences, you can compare the effects of market volatilities on Unicycive Therapeutics and ProMIS Neurosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of ProMIS Neurosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and ProMIS Neurosciences.
Diversification Opportunities for Unicycive Therapeutics and ProMIS Neurosciences
-0.52 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Unicycive and ProMIS is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and ProMIS Neurosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProMIS Neurosciences and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with ProMIS Neurosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProMIS Neurosciences has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and ProMIS Neurosciences go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and ProMIS Neurosciences
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 1.07 times more return on investment than ProMIS Neurosciences. However, Unicycive Therapeutics is 1.07 times more volatile than ProMIS Neurosciences. It trades about 0.03 of its potential returns per unit of risk. ProMIS Neurosciences is currently generating about 0.01 per unit of risk. If you would invest 82.00 in Unicycive Therapeutics on September 12, 2024 and sell it today you would lose (2.00) from holding Unicycive Therapeutics or give up 2.44% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. ProMIS Neurosciences
Performance |
| Timeline |
| Unicycive Therapeutics |
| ProMIS Neurosciences |
Unicycive Therapeutics and ProMIS Neurosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and ProMIS Neurosciences
The main advantage of trading using opposite Unicycive Therapeutics and ProMIS Neurosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, ProMIS Neurosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProMIS Neurosciences will offset losses from the drop in ProMIS Neurosciences' long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| ProMIS Neurosciences vs. biOasis Technologies | ProMIS Neurosciences vs. Zenith Capital Corp | ProMIS Neurosciences vs. Hemogenyx Pharmaceuticals Plc | ProMIS Neurosciences vs. Fennec Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |